Log In
BCIQ
Print this Print this
 

M012

  Manage Alerts
Collapse Summary General Information
Company Merganser Biotech Inc.
DescriptionHepcidin mimetic peptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationThalassemia
Indication DetailsTreat beta-thalassemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today